Abstract
Granules, an Indian producer of active pharmaceutical ingredients (APIs), will spend $84 million on an API plant and ancillary facilities, including an R&D unit, in Vishakhapatnam, India. International Finance Corp., a for-profit subsidiary of the World Bank, is enabling the project by buying $48 million in Granules bonds. IFC previously financed various Granules projects, including investment in cleaner production. The new plant will allow Granules to produce higher-end APIs, according to IFC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
